Clinical Trials Browser

Chemotherapy-induced Thrombocytopenia

NCT01428635 2023-09-26

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

Classical hematologyMyeloidOther hematologic neoplasm

Blast Crisis, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Primary Myelofibrosis

NCT01772420 2023-07-27

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Phase 2 Completed

52 enrolled 21 charts

Classical hematologyOther hematologic neoplasm

Anemia, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

NCT01168921 2023-03-23

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

23 enrolled 9 charts

Classical hematologyLymphoidOther hematologic neoplasm

Jacobs syndrome, Leukemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02323178 2021-04-20

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

Phase 1/2 Completed

30 enrolled

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

NCT01656252 2020-11-03

PrE0901

Phase 1/2 Terminated

15 enrolled 5 charts

Classical hematologyOther hematologic neoplasm

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT03701217 2018-10-09

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Phase 2/3 Unknown

220 enrolled

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myeloid, Acute

NCT02093325 2017-10-24

A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia

Phase 3 Unknown

83 enrolled

Classical hematology

Thrombocytopenia

NCT01484314 2017-03-15

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Phase 2 Terminated

1 enrolled 1 chart

Classical hematologyPlasma cell

Multiple Myeloma, Recurrence, Thrombocytopenia

NCT01500538 2016-02-15

VEIL

Phase 2 Terminated

1 enrolled

Classical hematologyLymphoid

Lymphoma, Lymphoma, Follicular, Thrombocytopenia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT01397149 2015-05-28

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Phase 1/2 Terminated

4 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

PrE0901

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

VEIL

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)